Restylane vs Juvederm: HA Filler Comparison
Comparing Solutions for Smile Lines
Both Restylane and Juvederm are safe and effective treatments for facial wrinkles or folds. These are the most popular dermal fillers on the market today. Both are made with hyaluronic acid, a natural component of your skin and connective tissues.
Compared to the collagen-based fillers of the past, these products are a major improvement. They not only last longer, but you can receive treatment the same day as the consultation – no allergy test or waiting time is needed. Let’s compare a few different aspects of the both products:
According to Allergan, Juvederm is the only HA filler FDA approved to last one year with a single treatment. Clinical studies cited on the official website say that Restylane been shown to last 18 months when patients returned for a touch-up treatment at 4.5 or 9 months.
The cost of Juvederm and Restylane is about the same. However, Juvederm is sold in a complete syringe, while Restylane is available in two sizes, which can be more economical.
Juvederm injectable gel has a smoother consistency than Restylane, which does not necessarily improve the treatment or its results.
FDA Approved Indications
Both products are approved and primarily used to treat nasolabial folds, or smile lines. Restylane has an additional indication for lip augmentation.
Allergan offers the Brilliant Distinctions program that includes Botox, Juvederm, Latisse, and Natrelle breast implants. A less robust offering called “Restylane Rewards” is available through Medicis, the maker of Restylane.
Physicians as well as patients tend to have their own personal preferences based on past experience with each product.
When it’s time to decide between them, trust your provider’s recommendation first, because it takes a trained hand to administer Juvederm, Restylane or any other dermal filler. These treatments provide temporary results. So if you don’t like the outcome, you can always try the other filler during your next visit.
Photo by @boetter on Flickr
Comments are closed.